Brainsway Partners With U.S. Navy to Provide Innovative Deep Transcranial Magnetic Stimulation (Deep TMS) for Depression Treatment
06 oct. 2015 10h00 HE
|
BrainsWay Ltd.
PHILADELPHIA, Oct. 06, 2015 (GLOBE NEWSWIRE) -- Brainsway (TASE:BRIN), the leader in the development of advanced noninvasive treatments for brain disorders, today announced its partnership with...
Brainsway Expands Management Team With Appointment of Joseph Perekupka as VP of Sales Operations, North America
10 sept. 2015 09h00 HE
|
BrainsWay Ltd.
HAR HAHOZVIM, Israel, Sept. 10, 2015 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN), a leading company developing revolutionary brain disorder treatments, announced that Joseph Perekupka has joined...
Brainsway Appoints Avi Posen as VP Global Sales
17 août 2015 15h00 HE
|
BrainsWay Ltd.
JERUSALEM, Aug. 17, 2015 (GLOBE NEWSWIRE) -- Brainsway Ltd (TASE:BRIN) announced this week that it has appointed Avi Posen to the position of VP Global Sales, effective August 16th, 2015.
Posen...
Brainsway Launches Distribution Company in the U.S.
30 déc. 2014 08h00 HE
|
BrainsWay Ltd.
JERUSALEM, Dec. 30, 2014 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) announced that in light of developments in the U.S. market, including the increased interest in Brainsway's technology and...
Brainsway Receives IDE Approval From FDA for Launching Pivotal PTSD Multi-Center Trial
15 déc. 2014 08h00 HE
|
BrainsWay Ltd.
JERUSALEM, Dec. 15, 2014 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) announced that it received an IDE (Investigational Device Exemptions) approval from the FDA for launching a Multi-Center trial...
Brainsway Receives CE Approvals for Treating Multiple Sclerosis (MS), Stroke and Obsessive Compulsive Disorder (OCD)
04 déc. 2014 08h00 HE
|
BrainsWay Ltd.
JERUSALEM, Dec. 4, 2014 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) announced that it received a CE Marketing Approval, enabling it to immediately market and sell Brainsway Deep TMS (Deep...
Brainsway Wins 2014 FLC Mid-Atlantic Regional Award for Excellence in Technology Transfer
13 oct. 2014 09h00 HE
|
BrainsWay Ltd.
JERUSALEM, Oct. 13, 2014 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) announced that its Deep TMS treatment has won the 2014 Federal Laboratory Consortium for Technology Transfer (FLC) Mid-Atlantic...
Brainsway Deep TMS Brings Substantial Improvement to OCD Patients in Deep TMS Study
30 sept. 2014 08h39 HE
|
BrainsWay Ltd.
JERUSALEM, Sept. 30, 2014 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to report substantial improvement in OCD (Obsessive-Compulsive Disorder) patients following Brainsway Deep TMS...
Results Announced for Study of Major Depression Patients Who Did Not Respond to Medication Treatments
05 juin 2014 15h58 HE
|
BrainsWay Ltd.
JERUSALEM, June 5, 2014 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce the final results for a study examining the safety and effectiveness of Brainsway's technology for...
Brainsway Receives FDA Approval of IDE for Obsessive-Compulsive Disorder Study
19 déc. 2013 08h32 HE
|
BrainsWay Ltd.
JERUSALEM, Dec. 19, 2013 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce that the U.S. Food and Drug Administration ("FDA") has approved an Investigational Device Exemption...